LSP Dementia Fund Overview
EQT Life Sciences, formerly LSP, is a leading European life sciences investor with a 30-year history, focusing on innovative companies developing therapeutics, medical devices, diagnostics, and healthtech solutions globally. With approximately €3.5 billion raised across 12 private funds and three investment strategies, EQT Life Sciences has invested in over 150 private companies. The team comprises experienced professionals with backgrounds in medicine, science, and industry, aiming to transform cutting-edge scientific innovation into impactful healthcare solutions.
Is LSP Dementia Fund the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with LSP Dementia Fund, along with a list of other relevant VCs, is available on Hopohopo.io.
LSP Dementia Fund
Investment focus
Product type
- Drugs / Pharma
Industries / verticals
- BioTech & Life Sciences
- MedTech & Devices
- PharmaTech
Investment role
Lead and follow
Stages
Series A, Series B or later
First ticket size
€10,000,000 - €60,000,000
Contact information
Officemanager
Suzanne Dwinger
Partner
Geraldine O'Keeffe
Partner
Joachim Rothe
Partner
Felice Verduyn
Partner
Mark Wegter
How to approach funds like LSP Dementia Fund
When engaging EQT Life Sciences, founders should highlight the clinical and commercial potential of their innovation, especially how it addresses significant unmet medical needs or redefines standards of care. Demonstrating robust scientific validation, a clear regulatory pathway, and a credible plan for scaling within global healthcare markets will resonate. Articulate how your team’s expertise and vision align with the demands of complex, high-impact healthcare ventures, and be prepared to discuss both near-term milestones and long-term value creation.
Find the best-fitting investors for your startup
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.
